> Detailanzeige

Dave, Dhaval M. [VerfasserIn] ; Erten, Bilge [Sonstige Person, Familie und Körperschaft]; Hummel, David W. [Sonstige Person, Familie und Körperschaft]; Keskin, Pinar [Sonstige Person, Familie und Körperschaft]; Zhang, Shuo [Sonstige Person, Familie und Körperschaft] National Bureau of Economic Research

Fighting Abuse with Prescription Tracking

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Book
  • Titel: Fighting Abuse with Prescription Tracking : Mandatory Drug Monitoring and Intimate Partner Violence
  • Beteiligte: Dave, Dhaval M. [VerfasserIn]; Erten, Bilge [Sonstige Person, Familie und Körperschaft]; Hummel, David W. [Sonstige Person, Familie und Körperschaft]; Keskin, Pinar [Sonstige Person, Familie und Körperschaft]; Zhang, Shuo [Sonstige Person, Familie und Körperschaft]
  • Körperschaft: National Bureau of Economic Research
  • Erschienen: Cambridge, Mass: National Bureau of Economic Research, June 2024
  • Erschienen in: NBER working paper series ; no. w32563
  • Umfang: 1 Online-Ressource; illustrations (black and white)
  • Sprache: Englisch
  • Schlagwörter: General ; Health Behavior ; Government Policy; Regulation; Public Health ; Marriage; Marital Dissolution; Family Structure; Domestic Abuse ; Economics of Gender; Non-labor Discrimination
  • Reproduktionsnotiz: Hardcopy version available to institutional subscribers
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: The opioid crisis generates broader societal harms beyond direct health and economic effects, impacting non-users through adverse spillovers on children, families, and communities. We study the spillover effects of a supply-side policy aimed at reducing the over-prescribing of opioids on women's wellbeing by examining its effects on intimate partner violence (IPV). Using administrative data on incidents reported to law enforcement, in conjunction with quasi-experimental variation in the adoption of stringent mandatory access prescription drug monitoring programs, we find that these policies have generated a downstream benefit for women by significantly reducing their overall exposure to IPV and IPV-involved injuries by 9 to 10 percent. Strongest effects are experienced by groups with higher rates of opioid consumption at baseline, including non-Hispanic Whites. However, we also find a significant uptick in heroin-involved IPV incidents, suggesting substitution into illicit drug consumption. Our results highlight the need to identify high-risk groups prone to switching to illicit opioids and to address this risk through evidence-based policies. Accounting for effects on IPV adds to the estimated societal burden of the opioid epidemic